Molecular switches that let a physician turn a therapeutic on, dial it back, or switch it off entirely — wirelessly, in real time, from outside the body.
A drug enters the body and runs at full strength until it's metabolized and gone. For a headache, that's fine. For a cancer treatment or a condition requiring precision — it isn't.
There is no off switch. No way to respond when a patient's needs change mid-course. No way to reduce a dose that's causing harm. No way to modulate on demand.
The protein is off by default. A wireless signal switches it on — and can switch it off again just as quickly. The physician controls activity from outside the body, in real time, without another clinical intervention.
The underlying architecture is protein-agnostic. The same platform applies across different therapeutic contexts without redesigning from scratch each time. One platform, built to be the foundation molecular robotics gets built on top of.
Interested in programmable therapeutics, molecular robotics, or adaptive biologics?
→ mattdemp276@gmail.com